David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TALKW
3726
DELISTED
Talkspace Inc Warrant
TALKW
| $94.1K | ﹤0.01% |
817,475
+678,869
| +490% | +$61.1K |
|
3727
CALL
TG Therapeutics
TGTX
$8.56B
| $93.6K | ﹤0.01% |
11,200
| – | – |
|
3728
Garrett Motion
GTX
$4.87B
| $93.4K | ﹤0.01% |
+11,853
| New | +$91.3K |
|
3729
RUM Group Inc
RUM
$4.88B
| $93K | ﹤0.01% |
18,239
-7,103
| -28% | -$53.1K |
|
|
MRNS
3730
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $91.8K | ﹤0.01% |
11,400
-343,348
| -97% | -$2.86M |
|
3731
Polestar Automotive Holding ADS Class C-1
PSNYW
$575M
| $91.5K | ﹤0.01% |
7,682
| – | – |
|
3732
Nuvation Bio
NUVB
$2.43B
| $91.1K | ﹤0.01% |
67,971
-44,265
| -39% | -$73.7K |
|
|
BHR
3733
Braemar Hotels & Resorts
BHR
$140M
| $90.7K | ﹤0.01% |
+32,727
| New | +$102K |
|
3734
American Well
AMWL
$201M
| $89.9K | ﹤0.01% |
3,841
+916
| +31% | +$30.9K |
|
3735
UWM Holdings
UWMC
$2.28B
| $89.3K | ﹤0.01% |
18,419
-18,586
| -50% | -$107K |
|
|
WHWK
3736
Whitehawk Therapeutics
WHWK
$288M
| $89.3K | ﹤0.01% |
+18,450
| New | +$107K |
|
|
DMAQR
3737
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
| $89K | ﹤0.01% |
296,800
| – | – |
|
|
DZSI
3738
DELISTED
DZS Inc. Common Stock
DZSI
| $88.5K | ﹤0.01% |
+42,132
| New | +$121K |
|
|
MRSN
3739
DELISTED
Mersana Therapeutics
MRSN
| $86.1K | ﹤0.01% |
2,711
-36,719
| -93% | -$1.75M |
|
|
SLGCW
3740
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $85.9K | ﹤0.01% |
390,303
| – | – |
|
3741
Mistras Group
MG
$608M
| $85.7K | ﹤0.01% |
15,725
-42,642
| -73% | -$268K |
|
3742
Joby Aviation
JOBY
$7.1B
| $85.3K | ﹤0.01% |
+13,230
| New | +$104K |
|
3743
InnovAge Holding
INNV
$1.49B
| $83.7K | ﹤0.01% |
13,970
-2,513
| -15% | -$16.3K |
|
3744
Rocket Lab Corp
RKLB
$42.9B
| $81.6K | ﹤0.01% |
18,630
-14,300
| -43% | -$87K |
|
3745
MaxCyte
MXCT
$142M
| $78.5K | ﹤0.01% |
25,162
-23,420
| -48% | -$94.2K |
|
|
KNTE
3746
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $78.1K | ﹤0.01% |
55,810
-4,299
| -7% | -$10.3K |
|
3747
CALL
Stem
STEM
$54.2M
| $75K | ﹤0.01% |
885
+170
| +24% | +$19.4K |
|
|
CLLS
3748
Cellectis
CLLS
$341M
| $74.5K | ﹤0.01% |
47,154
-31,675
| -40% | -$61.9K |
|
3749
Goldgroup Mining
GORO
$265M
| $73.9K | ﹤0.01% |
172,604
+96,646
| +127% | +$51.7K |
|
|
CIM
3750
Chimera Investment
CIM
$965M
| $73K | ﹤0.01% |
4,459
-1,572
| -26% | -$27.6K |
|
Similar funds
David Shaw's Q3 2023 Portfolio in Review
As of Q3 2023, David Shaw held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $2.99B in Q3 2023, closing 472 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- David Shaw's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- David Shaw added most to Amazon in Q3 2023, an estimated $516M increase.
- David Shaw's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- David Shaw fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- David Shaw's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- David Shaw opened 482 new positions and closed 472 in Q3 2023.
- David Shaw's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.